Heke M, Assmann A, Kröpil P, Ptok L, Hafner D, Ohmann C, Martens A, Karlu? A, Emmert MY, Kutschka I, Sievers HH, Klein HM. Laser-Supported CD133+ Cell Therapy in Patients with Ischemic Cardiomyopathy: Initial Results from a Prospective Phase I Multicenter Trial. Global Medical Discovery [ISSN 1929-8536].

Heke M, Klein HM.  Endogenous Laser Induced Ventricular Enhancement: a novel approach for Heart Failure. Meditrial Europe, 28 October 2014, ref. Heke and Klein, J Stem Cell Res Ther 2014, 4:9.

Heke M, Klein HM.  Endogenous Laser Induced Ventricular Enhancement (ELIVE™) therapy: A new paradigm for treating heart failure? J Stem Cell Res Ther 2014: Volume 4, Issue 9, 4:236, doi: 10.4172/2157-7633.1000236.

Heke M, Assmann A, Kröpil P, Ptok L, Hafner D, Ohmann C, Martens A, Karlu? A, Emmert MY, Kutschka I, Sievers HH, Klein HM. Laser-Supported CD133+ Cell Therapy in Patients with Ischemic Cardiomyopathy: Initial Results from a Prospective Phase I Multicenter Trial. .PLoS One. 2014 Jul 7;9(7): e101449. doi: 10.1371.

Klein HM, Assmann A, Heke M.  Addendum to ‘Intraoperative CD133+ cell transplantation during coronary artery bypass grafting in ischemic cardiomyopathy’. Multimed Man Cardiothorac Surg MMCTS 2014 Jun 2;2014. Epub 2014 Jul 2.

Bahudhanapati H, Potta SP, Heke M, Sirisala H, Hescheler, J.  Stem cell therapy for treating the failing heart. Current Opinion in Pharmacology, 2014, Review. Manuscript Number: COPHAR-S-13-00104.

Potta SP, Saric, T, Heke M, Hescheler, J.  Human-Induced Pluripotent Stem Cells, Embryonic Stem Cells, and Their Cardiomyocyte Derivatives: An Overview. Book chapter. Stem Cells Handbook, 2013, pp. 321-345, ISBN 978-1-4614-7695-5 (Print), 978-1-4614-7696-2 (Online).

Klein M, Assmann A, Lichtenberg A, Heke M. INSTEM trial – intraoperative procedure for TMLR-supported, autologous CD133+ cell transplantation during CABG; TCTMD, January 2012, CRF Conference on Cell Therapy for Cardiovascular Disease.

Assmann A, Heke M, Lichtenberg A, Klein M. INSTEM trial – intraoperative, autologous CD133+ cell isolation and TMLR-supported transplantation during CABG; JSRM, 2012 submitted.

Klein HM, Assmann A, Lichtenberg A, Heke M. Intraoperative CD133+ stem cell transplantation during coronary artery bypass grafting in ischemic cardiomyopathy. Multimed Man Cardiothorac Surg MMCTS 2010 Aug 9; doi:10.1510/ mmcts.2009.0039472009

Assmann A, Heke M, Schubert D, Lichtenberg A, Klein M.  INSTEM trial – intraoperative, autologous CD133+ stem cell isolation and TMLR-supported transplantation during CABG.  Human Gene Therapy 2009 Nov; Vol.20 (Issue 11): 1389-1389.

Klein HM, Ruhparwar A, Heke M, Gams E.  Intramyocardial Implantation of CD 133+Stem Cells Improve Cardiac Function without Bypass Surgery.  Tissue Engineering, 2009 Mar; Vol.15 (Issue 3): 715-715.

Klein HM, Ghodsizad A, Marktanner R, Poll L, Voelkel T, Mohammad Hasani MR, Piechaczek C, Feifel N, Stockschlaeder M, Burchardt ER, Kar BJ, Gregoric I, Gamd E.  Intramyocardial  implantation of CD133+ stem cells improved cardiac function without bypass surgery. Heart Surg Forum. 2007; 10 (1): E66-9.

Bara E, Ghodsizad A, Niehus M, Makoui M, Piechaczek C, Martin U, Warnecke G, Karck M, Gams E, Klein HM, Haverich A, Ruparwar A.  In vivo echocardiographic imaging of transplanted human adult stem cells in the myocardium labeled with clinically applicable CliniMACS nanoparticles. J Am Soc Echocardiogr. 2006 May; 19 (5): 563-8.

Ghodsizad A, Ruhparwar A, Marktanner R, Borowski A, Hasani MR, Polll L, Vshivkov I, Stold V, Voelkel T Piechaczek C, Burchardt ER, Stockschlaeder M, Sucker C, Gams E, Klein HM.  Autologous transplantation of CD133+ BM-derived stem cells as a therapeutic option for dilatative cardiomypathy. Cythotherapy. 2006; 8 (3): 308-10.

Ruhparwar A., Ghodsizad A., Gams E., Klein HM., Haverich A. et al.  Imaging of transplanted BMCs in pocrine heart using magnetic nanoparticles; A novel method fulfilling the GMP criteria. Circulation, Mai 2005.

Schulte am Esch J., Knoefel W.T., Klein HM., Ghodsizad A., Fürst G., Poll L.W., Stockschläder M., Peiper M., Hosch S.B..  Portal application of autologous CD133+ bone marrow cells to the liver – a novel concept to support hepatic regeneration.

Stem Cells, Volume 23, Number 4, April 2005.

Ghodsizad A., Klein HM., Borowski A. et al.  Intraoperative Isolation and Processing of ACC 133+ bone marrow derived stem cells. Cytotherapy, 2004; 6(5): 523-6.

Klein HM., Ghodsizad A., Borowski A. et al.  Autologous Bone Marrow derived Stem Therapy in Combination With TMLR: A Novel Therapeutic Option for Endstage Coronary Heart Disease. Heart Surgery Forum Oct 2004.